Delivery Order SPE2DB22D3011-SPE2DB24FQ2NK

Award Date 7/11/24
Potential Completion Date 7/12/24
Potential Value $2.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CONTRAVE ER 8-90 MG TABLET 120S. The contract has a ceiling value of $2,342.27 and a period of performance through February 27, 2025. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $3,879.04 firm-fixed-price contract is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication. The contract has an ultimate completion date of November 2, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CONTRAVE ER 8-90 MG TABLET 120S. The contract has a firm fixed price of $7,792.96 and a completion date of February 5, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CONTRAVE ER 8-90 mg tablets. The award, valued at $23,339.77, has an ultimate completion date of August 13, 2024. The contract is a firm fixed-price delivery order without a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, worth $1,326.04, is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a medication. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of November 14, 2023. There is no set-aside designation for this contract. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $35,904.99, is for the provision of CONTRAVE ER 8-90 MG TABLET 120S, a medication. The contract has a firm fixed price and is set to expire on May 31, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has a ceiling value of $25,229.12 and an ultimate completion date of November 30, 2023. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of CONTRAVE ER 8-90 MG TABLET 120S. The contract has a ceiling value of $6,472.77 and a completion date of August 30, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to supply a wide range of medications and medical supplies to military treatment...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,063.16, is for the delivery of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of May 31, 2024. This contract is not designated as a set-aside. Amerisourcebergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $1,534.21 fixed-price contract is for the supply of 4565220299 CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of July 23, 2024. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) to...
  • SPE2DB22D3011
    Indefinite Delivery Contract
  • SPE2DB22D3011-SPE2DB24FQ2NK
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication, with a ceiling value of $2,495.78 and a period of performance through July 12, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/17/25, 9:45 AM